GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort NeuroScientific Corp (HKSE:02172) » Definitions » Asset Turnover

MicroPort NeuroScientific (HKSE:02172) Asset Turnover : 0.20 (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is MicroPort NeuroScientific Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. MicroPort NeuroScientific's Revenue for the six months ended in Jun. 2024 was HK$439.5 Mil. MicroPort NeuroScientific's Total Assets for the quarter that ended in Jun. 2024 was HK$2,191.8 Mil. Therefore, MicroPort NeuroScientific's Asset Turnover for the quarter that ended in Jun. 2024 was 0.20.

Asset Turnover is linked to ROE % through Du Pont Formula. MicroPort NeuroScientific's annualized ROE % for the quarter that ended in Jun. 2024 was 17.03%. It is also linked to ROA % through Du Pont Formula. MicroPort NeuroScientific's annualized ROA % for the quarter that ended in Jun. 2024 was 14.10%.


MicroPort NeuroScientific Asset Turnover Historical Data

The historical data trend for MicroPort NeuroScientific's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort NeuroScientific Asset Turnover Chart

MicroPort NeuroScientific Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Asset Turnover
0.55 0.40 0.36 0.33 0.35

MicroPort NeuroScientific Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Asset Turnover Get a 7-Day Free Trial Premium Member Only 0.15 0.21 0.16 0.19 0.20

Competitive Comparison of MicroPort NeuroScientific's Asset Turnover

For the Medical Devices subindustry, MicroPort NeuroScientific's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MicroPort NeuroScientific's Asset Turnover Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort NeuroScientific's Asset Turnover distribution charts can be found below:

* The bar in red indicates where MicroPort NeuroScientific's Asset Turnover falls into.



MicroPort NeuroScientific Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

MicroPort NeuroScientific's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=728.045/( (2029.071+2144.508)/ 2 )
=728.045/2086.7895
=0.35

MicroPort NeuroScientific's Asset Turnover for the quarter that ended in Jun. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=439.472/( (2144.508+2239.123)/ 2 )
=439.472/2191.8155
=0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


MicroPort NeuroScientific  (HKSE:02172) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

MicroPort NeuroScientific's annulized ROE % for the quarter that ended in Jun. 2024 is

ROE %**(Q: Jun. 2024 )
=Net Income/Total Stockholders Equity
=308.976/1814.121
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(308.976 / 878.944)*(878.944 / 2191.8155)*(2191.8155/ 1814.121)
=Net Margin %*Asset Turnover*Equity Multiplier
=35.15 %*0.401*1.2082
=ROA %*Equity Multiplier
=14.10 %*1.2082
=17.03 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) net income data. The Revenue data used here is two times the semi-annual (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

MicroPort NeuroScientific's annulized ROA % for the quarter that ended in Jun. 2024 is

ROA %(Q: Jun. 2024 )
=Net Income/Total Assets
=308.976/2191.8155
=(Net Income / Revenue)*(Revenue / Total Assets)
=(308.976 / 878.944)*(878.944 / 2191.8155)
=Net Margin %*Asset Turnover
=35.15 %*0.401
=14.10 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) net income data. The Revenue data used here is two times the semi-annual (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


MicroPort NeuroScientific Asset Turnover Related Terms

Thank you for viewing the detailed overview of MicroPort NeuroScientific's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroPort NeuroScientific Business Description

Traded in Other Exchanges
N/A
Address
No. 1661 Zhangdong Road, Pudong New Area, Shanghai, CHN
MicroPort NeuroScientific Corp formerly MicroPort NeuroTech Ltd is into the neuro-interventional medical device industry, dedicated to providing solutions for physicians and patients. The company boast a comprehensive portfolio of approved therapeutic products covering all of the three main areas of neurovascular disease, namely hemorrhagic stroke, cerebral atherosclerotic stenosis and acute ischemic stroke.
Executives
Microport Scientific Corporation
Hu Yibin
Biolink Biomedical Ltd. 2201 Interest of corporation controlled by you
Blossom Vision Limited 2201 Interest of corporation controlled by you
Lion Fish Limited 2201 Interest of corporation controlled by you
Suntera Corporate Trustees (hong Kong) Limited 2301 Trustee
Thriving Hope Limited 2201 Interest of corporation controlled by you
Biolink Fund Limited Partnership 2201 Interest of corporation controlled by you
Biolink Limited 2101 Beneficial owner
Microport Scientific Investment Ltd
Maxwell Maxcare Science Foundation Limited
We'tron Capital Limited

MicroPort NeuroScientific Headlines

No Headlines